3D-Printed Artificial Axons for Neural Tissue Modeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current devices for studying neurological diseases and neural cell interactions, such as 2D polystyrene tissue culture dishes and organotypic cultures, fail to replicate the complex three-dimensional environment of neurons, leading to oversimplification and variability, which hinders the understanding of underlying mechanisms and the development of therapies for neurological diseases.

Innovation Solution

Development of cell-mimetic devices with fibers made from hexanediol diacrylate (HDDA) and polyethylene glycol (PEG) derivatives, offering tunable elastic moduli and geometries similar to neuronal axons, allowing for systematic study of cell interactions and drug responses in a more biologically relevant environment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If 2D polystyrene tissue culture dishes are used, then the device is simple and easy to manufacture, but it oversimplifies the in vivo environment and fails to replicate three-dimensional neural tissue structure

Engineering Contradiction:
Improveease of manufactureVSAvoidstructural complexity
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

The patent transitions from two-dimensional polystyrene dishes to three-dimensional printed structures with vertical pillars and suspended fibers, adding the third dimension to replicate the complex architecture of neural tissue while maintaining manufacturing feasibility through additive manufacturing

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Device complexity

If organotypic culture using tissue slices is used, then the device provides a more similar in vivo environment, but there is inherent variability among neuronal cultures and tissue slices

Engineering Contradiction:
Improveenvironmental similarityVSAvoidreproducibility
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent segments the neural tissue environment into discrete, controllable elements (individual pillars and fibers with specific diameters and spacing) that can be systematically varied and reproduced, replacing the heterogeneous variability of tissue slices with controlled geometric parameters

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses parameter changes in fiber diameter (0.1-20 μm), pillar height, and spacing to systematically control the microenvironment, allowing reproducible variation of physical cues while maintaining environmental similarity to neural tissue

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If existing cell culture devices are used, then the device is simple, but it cannot provide systematic isolation of individual physical and chemical cues

Engineering Contradiction:
ImprovesimplicityVSAvoidisolation of physical cues
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The patent applies local quality by creating specific geometric features (different fiber diameters, pillar heights, and spacing) at different locations within the device to isolate and test individual physical cues on cell behavior, enabling systematic study of how each parameter independently affects neural cell interactions

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These devices provide a reproducible and reductionist model that mimics the mechanical and biochemical properties of neuronal axons, enabling detailed studies of myelination and drug effects, improving the understanding and potential treatment of neurological diseases.

Implementation Method 1

The method further includes exposing the resin bath to the light source causing an exposed portion of the material to cure

Methodology Applied
Scientific EffectPhotopolymerization: Photopolymerisation

Data Source

PatentUS20230107666A1Engineered 3D-Printed Artificial Axons
Publication Date: 2023.04.06 MASSACHUSETTS INST OF TECH
  • US20230107666A1 patent drawing
  • US20230107666A1 patent drawing
  • US20230107666A1 patent drawing

AI summary

Materials and methods for cell-mimetics having mechanical properties of biological neural axons are provided. A cell-mimetic device includes an array of fibers comprised of hexanediol diacrylate (HDDA) or an HDDA derivative, and at least one derivative of polyethylene glycol (PEG) selected from the group consisting of: PEG-acrylate, PEG-diacrylate, and any multi-arm PEG-acrylate.